Allergy medications used in asthma management
Pro Research Analysisby 
Searched over 200M research papers
Allergy Medications in Asthma Management: Key Drug Classes and Their Roles
Asthma, especially allergic asthma, is commonly managed with a combination of medications that target both airway inflammation and the underlying allergic response. The main classes of allergy medications used in asthma management include inhaled corticosteroids, antihistamines, biologics, and allergen immunotherapy. Each plays a distinct role in controlling symptoms and improving patient outcomes Falk2018Kruse2018Sullivan2019+1 MORE.
Inhaled Corticosteroids and Long-Acting Bronchodilators
Inhaled corticosteroids (ICS) are the cornerstone of asthma management, effectively reducing airway inflammation and controlling symptoms in most patients. They are often combined with long-acting bronchodilators for better control, especially in moderate to severe cases. However, a subset of patients with allergic asthma may remain uncontrolled despite high-dose ICS and additional controller medications, highlighting the need for alternative or add-on therapies Falk2018Sullivan2019Chipps2017.
Antihistamines and Their Limitations
Antihistamines are commonly used to manage allergic symptoms, but their role in asthma control is limited. While they can help with comorbid allergic rhinitis, they are not sufficient for controlling asthma itself. Additionally, long-term use of antihistamines and steroids can lead to undesirable side effects, and some patients may not respond adequately to these medications .
Biologic Therapies: Targeted Allergy Medications
Biologic medications, such as omalizumab (an anti-IgE monoclonal antibody), have become important for patients with moderate-to-severe persistent allergic asthma that is not controlled by standard therapies. Omalizumab is approved for use in both adults and children (aged 6 and older) and has been shown to reduce exacerbations, decrease corticosteroid use, and improve quality of life in clinical trials and real-world studies . These biologics target specific immune pathways involved in the allergic response, offering a more personalized approach for treatment-resistant patients Falk2018Kruse2018Chipps2017.
Allergen Immunotherapy (AIT): Disease-Modifying Treatment
Allergen immunotherapy (AIT) is unique among allergy medications because it can modify the course of allergic asthma, not just control symptoms. AIT involves repeated exposure to specific allergens via subcutaneous injections (SCIT) or sublingual tablets/drops (SLIT), leading to long-term desensitization and immune system changes. Clinical evidence supports AIT as the only treatment capable of both improving symptoms and preventing the progression of allergic asthma Falk2018Fiala2023Batard2024+2 MORE.
- SCIT and SLIT: Both forms are effective, with SCIT recommended for children and adults with mild-to-moderate house dust mite (HDM)-sensitized allergic asthma, and SLIT (especially HDM SLIT-tablets) showing robust effects in adults Agache2019Nakagome2021.
- Long-term Benefits: AIT can provide lasting symptom relief even after treatment ends, reduce medication needs, and may prevent the development of new allergies or asthma in at-risk individuals Fiala2023Batard2024Nakagome2021.
- Combination with Biologics: For severe or difficult-to-treat cases, combining AIT with biologics is a promising strategy .
Medication Use Patterns in Allergic vs. Non-Allergic Asthma
Patients with allergic asthma tend to have worse asthma control and require higher doses of medications, including more frequent use of high-dose ICS and oral corticosteroids, compared to those with non-allergic asthma. This group may need more vigilant clinical oversight and tailored treatment plans to achieve adequate control .
Conclusion
Allergy medications play a central role in asthma management, especially for patients with allergic asthma. While inhaled corticosteroids and bronchodilators remain foundational, biologics and allergen immunotherapy offer targeted and disease-modifying options for those with persistent symptoms. The choice and combination of these therapies should be individualized based on asthma severity, allergy profile, and response to treatment, with ongoing research and drug repurposing efforts aiming to expand effective options for all patients Falk2018Kruse2018Sullivan2019+5 MORE.
Sources and full results
Most relevant research papers on this topic
Drug repurposing to treat asthma and allergic disorders: Progress and prospects
Drug repurposing could provide new, cheap, and convenient treatment options for asthma and allergy patients by repositioning effective and safe small-molecule drugs from other fields of medicine.
Clinical and Experimental Treatment of Allergic Asthma with an Emphasis on Allergen Immunotherapy and its Mechanisms.
Allergen immunotherapy (AIT) effectively treats allergic asthma by modifying the immune system, enabling individuals to live improved lives for years after treatment ends.
Allergen Immunotherapy for the Prevention and Treatment of Asthma
Allergen immunotherapy (AIT) effectively improves allergic asthma symptoms and prevents its onset and worsening, offering promising new treatment options for severe asthma patients.
Clinical Practice Guideline: Immunotherapy for Inhalant Allergy.
This guideline recommends limiting allergen immunotherapy to clinically relevant allergens, educating patients, and treating for a minimum of 3 years, with exceptions for patients with certain conditions.
DOI